cloudfront

Report Detail

Pharma & Healthcare Global Drugs for Malaria Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3319028
  • |
  • 15 April, 2019
  • |
  • Global
  • |
  • 115 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Global Drugs for Malaria Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

    1 Market Overview

    • 1.1 Drugs for Malaria Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Aryl Aminoalcohol Compounds
      • 1.2.2 Antifolate Compounds
      • 1.2.3 Artemisinin Compounds
    • 1.3 Market Analysis by Applications
      • 1.3.1 Prevention
      • 1.3.2 Treatment
      • 1.3.3 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Cipla
      • 2.1.1 Business Overview
      • 2.1.2 Drugs for Malaria Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Guilin Pharmaceutical
      • 2.2.1 Business Overview
      • 2.2.2 Drugs for Malaria Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 IPCA Laboratories
      • 2.3.1 Business Overview
      • 2.3.2 Drugs for Malaria Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 GlaxoSmithKline
      • 2.4.1 Business Overview
      • 2.4.2 Drugs for Malaria Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Mylan Labs
      • 2.5.1 Business Overview
      • 2.5.2 Drugs for Malaria Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Roche
      • 2.6.1 Business Overview
      • 2.6.2 Drugs for Malaria Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Novartis
      • 2.7.1 Business Overview
      • 2.7.2 Drugs for Malaria Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Sanofi Aventis
      • 2.8.1 Business Overview
      • 2.8.2 Drugs for Malaria Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Ajanta Pharma
      • 2.9.1 Business Overview
      • 2.9.2 Drugs for Malaria Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Drugs for Malaria Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Drugs for Malaria Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Drugs for Malaria Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Drugs for Malaria Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Drugs for Malaria Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Drugs for Malaria Market Analysis by Regions

    • 4.1 Global Drugs for Malaria Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Drugs for Malaria Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Drugs for Malaria Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 4.3 Europe Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 4.5 South America Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Drugs for Malaria Sales and Growth Rate (2014-2019)

    5 North America Drugs for Malaria by Country

    • 5.1 North America Drugs for Malaria Sales, Revenue and Market Share by Country
      • 5.1.1 North America Drugs for Malaria Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Drugs for Malaria Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 5.3 Canada Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Drugs for Malaria Sales and Growth Rate (2014-2019)

    6 Europe Drugs for Malaria by Country

    • 6.1 Europe Drugs for Malaria Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Drugs for Malaria Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Drugs for Malaria Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 6.3 UK Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 6.4 France Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 6.5 Russia Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 6.6 Italy Drugs for Malaria Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Drugs for Malaria by Country

    • 7.1 Asia-Pacific Drugs for Malaria Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Drugs for Malaria Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Drugs for Malaria Revenue and Market Share by Country (2014-2019)
    • 7.2 China Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 7.3 Japan Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 7.4 Korea Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 7.5 India Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Drugs for Malaria Sales and Growth Rate (2014-2019)

    8 South America Drugs for Malaria by Country

    • 8.1 South America Drugs for Malaria Sales, Revenue and Market Share by Country
      • 8.1.1 South America Drugs for Malaria Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Drugs for Malaria Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Drugs for Malaria Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Drugs for Malaria by Countries

    • 9.1 Middle East and Africa Drugs for Malaria Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Drugs for Malaria Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Drugs for Malaria Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Drugs for Malaria Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Drugs for Malaria Sales and Growth Rate (2014-2019)

    10 Global Drugs for Malaria Market Segment by Type

    • 10.1 Global Drugs for Malaria Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Drugs for Malaria Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Drugs for Malaria Revenue and Market Share by Type (2014-2019)
    • 10.2 Aryl Aminoalcohol Compounds Sales Growth and Price
      • 10.2.1 Global Aryl Aminoalcohol Compounds Sales Growth (2014-2019)
      • 10.2.2 Global Aryl Aminoalcohol Compounds Price (2014-2019)
    • 10.3 Antifolate Compounds Sales Growth and Price
      • 10.3.1 Global Antifolate Compounds Sales Growth (2014-2019)
      • 10.3.2 Global Antifolate Compounds Price (2014-2019)
    • 10.4 Artemisinin Compounds Sales Growth and Price
      • 10.4.1 Global Artemisinin Compounds Sales Growth (2014-2019)
      • 10.4.2 Global Artemisinin Compounds Price (2014-2019)

    11 Global Drugs for Malaria Market Segment by Application

    • 11.1 Global Drugs for Malaria Sales Market Share by Application (2014-2019)
    • 11.2 Prevention Sales Growth (2014-2019)
    • 11.3 Treatment Sales Growth (2014-2019)
    • 11.4 Other Sales Growth (2014-2019)

    12 Drugs for Malaria Market Forecast (2019-2024)

    • 12.1 Global Drugs for Malaria Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Drugs for Malaria Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Drugs for Malaria Market Forecast (2019-2024)
      • 12.2.2 Europe Drugs for Malaria Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Drugs for Malaria Market Forecast (2019-2024)
      • 12.2.4 South America Drugs for Malaria Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Drugs for Malaria Market Forecast (2019-2024)
    • 12.3 Drugs for Malaria Market Forecast by Type (2019-2024)
      • 12.3.1 Global Drugs for Malaria Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Drugs for Malaria Market Share Forecast by Type (2019-2024)
    • 12.4 Drugs for Malaria Market Forecast by Application (2019-2024)
      • 12.4.1 Global Drugs for Malaria Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Drugs for Malaria Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

      Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.

      Scope of the Report:
      The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.
      Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.
      Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States.
      The worldwide market for Drugs for Malaria is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Drugs for Malaria in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Cipla
      Guilin Pharmaceutical
      IPCA Laboratories
      GlaxoSmithKline
      Mylan Labs
      Roche
      Novartis
      Sanofi Aventis
      Ajanta Pharma

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Aryl Aminoalcohol Compounds
      Antifolate Compounds
      Artemisinin Compounds

      Market Segment by Applications, can be divided into
      Prevention
      Treatment
      Other

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Drugs for Malaria product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Drugs for Malaria, with price, sales, revenue and global market share of Drugs for Malaria in 2017 and 2018.
      Chapter 3, the Drugs for Malaria competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Drugs for Malaria breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Drugs for Malaria market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Drugs for Malaria sales channel, distributors, customers, research findings and conclusion, appendix and data source.


      Summary:
      Get latest Market Research Reports on Drugs for Malaria . Industry analysis & Market Report on Drugs for Malaria is a syndicated market report, published as Global Drugs for Malaria Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Drugs for Malaria market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report